Licensed & Unlicensed Indications

Misoprostol is currently only approved by the Food and Drug Administration (FDA) in the US for the prevention and treatment of gastric ulcers resulting from chronic administration of non-steroidal anti-inflammatory drugs (NSAIDS). In some other countries dedicated products for several indications in OB/Gyn have been marketed or are expected in the next years. Misoprostol has […]

Read More